TNBC - TRIPLE-NEGATIVE BREAST CANCER
Clinical trials for TNBC - TRIPLE-NEGATIVE BREAST CANCER explained in plain language.
Never miss a new study
Get alerted when new TNBC - TRIPLE-NEGATIVE BREAST CANCER trials appear
Sign up with your email to follow new studies for TNBC - TRIPLE-NEGATIVE BREAST CANCER, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Could a vaccine stop Triple-Negative breast cancer from coming back?
⭐️ VACCINE ⭐️ CompletedThis early-phase trial tests an experimental vaccine made from the alpha-lactalbumin protein, found in breast tissue, to see if it can safely train the immune system to fight triple-negative breast cancer cells. The study enrolls people who have completed treatment for non-metast…
Matched conditions: TNBC - TRIPLE-NEGATIVE BREAST CANCER
Phase: EARLY_PHASE1 • Sponsor: George T. Budd • Aim: ⭐️ VACCINE ⭐️
Last updated Jul 19, 2026 00:00 UTC
-
Triple-Drug cocktail aims to stall aggressive breast cancer
Disease control CompletedThis phase 2 trial is testing whether a combination of two chemotherapy drugs (nab-paclitaxel and cisplatin) plus an immunotherapy drug (camrelizumab) can help people with metastatic triple-negative breast cancer live longer without their disease getting worse. The study enrolls …
Matched conditions: TNBC - TRIPLE-NEGATIVE BREAST CANCER
Phase: PHASE2 • Sponsor: Fudan University • Aim: Disease control
Last updated Jul 23, 2026 00:00 UTC